CYP19A1 and hyperinsulinemic hypoglycemia, familial, 4: As in part expected, in 2 of these cases, treatment with intramuscular testosterone did not give skeletal benefit to these patients, since aromatase deficiency does not lead to low testosterone levels [5, 47].